BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3882550)

  • 1. Morphologic and immunohistochemical features of fulminant delta hepatitis.
    Govindarajan S; de Cock KM; Peters RL
    Hum Pathol; 1985 Mar; 16(3):262-7. PubMed ID: 3882550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fulminant B viral hepatitis: role of delta agent.
    Govindarajan S; Chin KP; Redeker AG; Peters RL
    Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant delta hepatitis in chronic hepatitis B infection.
    De Cock KM; Govindarajan S; Redeker AG
    JAMA; 1984 Nov; 252(19):2746-8. PubMed ID: 6387205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The liver during and after fulminant hepatitis.
    Horney JT; Galambos JT
    Gastroenterology; 1977 Oct; 73(4 Pt 1):639-45. PubMed ID: 892367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.
    Yoshiba M; Sekiyama K; Inoue K; Fujita R
    J Gastroenterol; 1995 Feb; 30(1):67-73. PubMed ID: 7719417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulminant hepatitis: Mayo Clinic experience with 34 cases.
    Rakela J; Lange SM; Ludwig J; Baldus WP
    Mayo Clin Proc; 1985 May; 60(5):289-92. PubMed ID: 3921780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of acute B viral hepatitis--role of delta agent.
    Govindarajan S; Valinluck B; Peters L
    Gut; 1986 Jan; 27(1):19-22. PubMed ID: 3949233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state.
    Chu CM; Liaw YF
    Infection; 1990; 18(4):200-3. PubMed ID: 2210850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiologic considerations of fulminant non-A, non-B viral hepatitis in Japan: analyses by nucleic acid amplification method.
    Fukai K; Yokosuka O; Fujiwara K; Tagawa M; Imazeki F; Saisho H; Omata M
    J Infect Dis; 1998 Aug; 178(2):325-33. PubMed ID: 9697711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey.
    Saracco G; Macagno S; Rosina F; Rizzetto M
    Ann Intern Med; 1988 Mar; 108(3):380-3. PubMed ID: 3341675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of hepatitis B antigens in hepatic tissue in various forms of acute hepatitis].
    Sarno EN; Vieira LM; Alvariz FG
    Arq Gastroenterol; 1984; 21(2):68-74. PubMed ID: 6393924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant viral hepatitis in Kuwait.
    Alkandari S; Mahbut S; Nordenfelt E; al-Nakib B; al-Nakib W
    Ann Trop Med Parasitol; 1988 Dec; 82(6):555-9. PubMed ID: 3151428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis non-A, non-B: epidemiologic, clinical, serologic and morphologic aspects].
    Spichtin HP
    Klin Wochenschr; 1985 May; 63(9):389-404. PubMed ID: 2582179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.
    Krajden S; Bishai F; Huang SN; Ronald A; Harris F; Kempston J; Anderson J; Keston S
    CMAJ; 1986 Dec; 135(11):1282-5. PubMed ID: 3536053
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis.
    Wright TL; Mamish D; Combs C; Kim M; Donegan E; Ferrell L; Lake J; Roberts J; Ascher NL
    Lancet; 1992 Apr; 339(8799):952-5. PubMed ID: 1348798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of hepatitis viral markers in patients with acute and chronic liver diseases in northern India.
    Irshad M; Acharya SK
    Intervirology; 1994; 37(6):369-72. PubMed ID: 8586538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults.
    Tassopoulos NC; Papaevangelou GJ; Sjogren MH; Roumeliotou-Karayannis A; Gerin JL; Purcell RH
    Gastroenterology; 1987 Jun; 92(6):1844-50. PubMed ID: 3569758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and clinical features of fulminant delta hepatitis.
    Smedile A; Saracco G; Caredda F; Gimson A; Milazzo F; Cargnel A; Dentico P; Caporaso N; Papaevangelou G
    Prog Clin Biol Res; 1983; 143():237-43. PubMed ID: 6669580
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunohistochemical detection of HBs, HBc and delta antigens in liver sections. Technics, value as a routine procedure according to the cycle of the viral disease and prospects for the future].
    Degott C; Paris R; Bonilla S; Potet F
    Ann Pathol; 1988; 8(3):175-83. PubMed ID: 3052481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.